Springer Antiviral Chemotherapy 5 - Advances in Biology 458

Explore the evolution of viral management in Antiviral Chemotherapy 5, part of the Advances in Experimental Medicine and Biology series. This volume provides a historical and scientific look at the shifts in HIV infection treatment following the New Directions in Antiviral Therapy conference. Readers gain insight into the development of second-site RT inhibitors and protease inhibitors, which changed how clinicians manage patients. The text examines the understanding of the clinical latency period, revealing it as a time of intense viral replication and CD4 lymphocyte turnover. It also covers the importance of measuring HIV RNA concentrations in plasma to monitor infection. This book serves as a foundational resource for medical professionals and researchers tracking the progression of antiviral research and clinical applications.